Tempest Therapeutics (TPST) Minority Interest (2016 - 2021)
Tempest Therapeutics (TPST) posted Minority Interest of $668000.0 for Q1 2021, little changed sequentially from $668000.0 in Q4 2020, and down 17.43% YoY from $809000.0 in Q1 2020.
Tempest Therapeutics (TPST) Minority Interest (2016 - 2021) Analysis & Trends
Tempest Therapeutics has reported Minority Interest for 6 years, with the latest figure at $668000.0 in Q1 2021.
- Quarterly Minority Interest fell 17.43% year-over-year to $668000.0 in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $668000.0 (down 17.43% YoY) and the FY2020 annual result came in at $668000.0, down 49.55% from the prior year.
- Minority Interest was little changed at $668000.0 in Q1 2021 per TPST's latest filing, from $668000.0 in the prior quarter.
- Over five years, Minority Interest peaked at $132.9 million in Q4 2017 and troughed at $668000.0 in Q2 2020.
- A 5-year average of $38.9 million and a median of $1.9 million in 2019 frame the typical range for Minority Interest.
- The sharpest annual moves came in 2017 and 2019: Minority Interest surged 52.79% in 2017, then slumped 98.68% in 2019.
- Over 5 years, Minority Interest stood at $132.9 million in 2017, then tumbled by 98.37% to $2.2 million in 2018, then slumped by 39.01% to $1.3 million in 2019, then plunged by 49.55% to $668000.0 in 2020, then changed by 0.0% to $668000.0 in 2021.
- According to Business Quant data, Minority Interest over the past three periods registered $668000.0, $668000.0, and $668000.0 for Q1 2021, Q4 2020, and Q3 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Tempest Therapeutics | 4.32 Mn | 3.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 668,000.00 |
| Dec 31, 2020 | 668,000.00 |
| Sep 30, 2020 | 668,000.00 |
| Jun 30, 2020 | 668,000.00 |
| Mar 31, 2020 | 809,000.00 |
| Dec 31, 2019 | 1.32 Mn |
| Sep 30, 2019 | 1.76 Mn |
| Jun 30, 2019 | 2.06 Mn |
| Mar 31, 2019 | 2.17 Mn |
| Dec 31, 2018 | 2.17 Mn |
| Sep 30, 2018 | 132.92 Mn |
| Jun 30, 2018 | 132.92 Mn |
| Mar 31, 2018 | 132.92 Mn |
| Dec 31, 2017 | 132.92 Mn |
| Dec 31, 2016 | 87.00 Mn |